Fig. 5From: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluationPredictive simulated pharmacokinetic parameters for vincristine. Plasma concentration vs time curve for using 1Â mg/kg as the initial IV dose (ADMET Predictor (TM) version 10.4.0.5, 64-bit)Back to article page